ribavirin has been researched along with Myocardial Infarction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abou-Samra, AB; Butt, AA; Freiberg, MS; Shaikh, OS; Shuaib, A; Yan, P | 1 |
| Macedo, G; Ribeiro, T | 1 |
2 other study(ies) available for ribavirin and Myocardial Infarction
| Article | Year |
|---|---|
Direct-Acting Antiviral Therapy for HCV Infection Is Associated With a Reduced Risk of Cardiovascular Disease Events.
Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Antiviral Agents; Cardiovascular Diseases; Coronary Artery Bypass; Drug Therapy, Combination; Female; Heart Failure; Hepatitis C, Chronic; Humans; Incidence; Interferon Type I; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Protective Factors; Ribavirin; Stroke; Sustained Virologic Response | 2019 |
Interferon plus ribavirin: a cautionary note.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Myocardial Infarction; Ribavirin | 1999 |